Cholangiocarcinoma is a rare tumor. Many cases are localized while metastat
ic disease within the liver and abdomen do occur. There is as yet no standa
rd therapy for advanced bile duct tumors. Radiotherapy and chemotherapy are
not curative modalities in this condition but are being assessed adjuvantl
y following surgery, and as palliative treatment in an attempt to either ex
tend progression-free and overall survival or to palliate symptoms. Advance
s may be made by: (i) The combined use of radiation and chemotherapy, (ii)
High dose conformal radiotherapy, (iii) Novel chemotherapeutic agents. Pati
ents should be given the opportunity to participate in clinical trials.